Maulik D Majmudar
Overview
Explore the profile of Maulik D Majmudar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Majmudar M, Harrington R, Brown N, Graham G, McConnell M
J Am Heart Assoc
. 2015 Oct;
4(10):e001990.
PMID: 26450117
No abstract available.
12.
Majmudar M, Colucci L, Landman A
Healthc (Amst)
. 2015 Sep;
3(3):153-6.
PMID: 26384227
The healthcare system is undergoing rapid transformation as national policies increase patient access, reward positive health outcomes, and push for an end to the current era of episodic care. Advances...
13.
Majmudar M, Murthy V, Shah R, Kolli S, Mousavi N, Foster C, et al.
Eur Heart J Cardiovasc Imaging
. 2015 Feb;
16(8):900-9.
PMID: 25719181
Aims: Patients with left ventricular systolic dysfunction frequently show abnormal coronary vascular function, even in the absence of overt coronary artery disease. Moreover, the severity of vascular dysfunction might be...
14.
Liong M, Im H, Majmudar M, Aguirre A, Sebas M, Lee H, et al.
Adv Healthc Mater
. 2014 Feb;
3(7):1015-9.
PMID: 24532323
A magnetic ligation method is utilized for the detection of microRNAs among a complex biological background without polymerase chain reaction or nucleotide modification. The sandwich probes assay can be adapted...
15.
Majmudar M, Keliher E, Heidt T, Leuschner F, Truelove J, Sena B, et al.
Circulation
. 2013 Apr;
127(20):2038-46.
PMID: 23616627
Background: Exaggerated and prolonged inflammation after myocardial infarction (MI) accelerates left ventricular remodeling. Inflammatory pathways may present a therapeutic target to prevent post-MI heart failure. However, the appropriate magnitude and...
16.
Majmudar M, Yoo J, Keliher E, Truelove J, Iwamoto Y, Sena B, et al.
Circ Res
. 2013 Jan;
112(5):755-61.
PMID: 23300273
Rationale: Myeloid cell content in atherosclerotic plaques associates with rupture and thrombosis. Thus, imaging of lesional monocytes and macrophages could serve as a biomarker of disease progression and therapeutic intervention....
17.
Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins C, et al.
Nature
. 2012 Jul;
487(7407):325-9.
PMID: 22763456
During progression of atherosclerosis, myeloid cells destabilize lipid-rich plaques in the arterial wall and cause their rupture, thus triggering myocardial infarction and stroke. Survivors of acute coronary syndromes have a...
18.
Majmudar M, Nahrendorf M
J Nucl Med
. 2012 Apr;
53(5):673-6.
PMID: 22492729
Despite significant advancements in medical and device-based therapies, cardiovascular disease remains the number one cause of death in the United States. Early detection of atherosclerosis, prevention of myocardial infarction and...
19.
Senthilkumar A, Majmudar M, Shenoy C, Kim H, Kim R
Heart Fail Clin
. 2009 Jul;
5(3):349-67, vi.
PMID: 19564013
In patients who have heart failure, treatment and survival are directly related to the cause. Clinically, as a practical first step, patients are classified as having either ischemic or non-ischemic...
20.
Majmudar M, Tompkins C, Bachmann J, Blumenthal R, Marine J
Cardiol Rev
. 2009 Apr;
17(2):60-9.
PMID: 19367147
Sudden cardiac death remains a leading cause of mortality in the United States, with an incidence of 300,000 to 400,000 deaths annually. Despite advances in the management of cardiovascular disease,...